STAT News

STAT+: A journey to witness China’s biotech boom up close

Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.

By STAT News

1 min read
STAT+: A journey to witness China’s biotech boom up close
STAT+: A journey to witness China’s biotech boom up close

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights